Per the June 2011 financial report, the accounts receivable is their short term cash flow to pay the current debt. Luckily, they most likely don't have the same issues of not being able to get standard bank loans as they did during the recession. It's very difficult to convince a BK court that you want to go bankrupt when you owe virtually NO long term debt and your net worth is on the $40+ mil positive side while at the same time a net profit albeit small.
Obviously The Barclay Group didn't just buy the company to take it to bankruptcy. But they may sell off a subsidiary or two to raise some serious cash. Bottom line for an OTC company, the financial is in pretty good shape for a $100+ mil revenue company in comparison with some other companies of the same size trading on the big boards.
My question is whether The Barclay Group is going to put $s into the company and reorganize and restructure with a higher exchange, etc., or throw it to the wolves. Hard to imagine that founder Philip Verges would have agreed to the latter. It will be interesting to see the progression of the outline of change that was shown from the Oct 2011 PR and the link submitted with the recent Philip Verges buyout PR a few days ago.
Market Data 
Markets 
AI
